Veterinary Antimicrobial Susceptibility Testing Market Size
Antimicrobial Susceptibility Testing in Veterinary Medicine Rising concerns about antimicrobial resistance suggest that market size will show significant increase between 2024 and 2032. Rising government measures to address antimicrobial resistance are driven by expanding demand for animal-derived products, growing need for pet insurance and higher healthcare expenditure.
Testing for antimicrobial resistance (AMR) is becoming more crucial given the rising demand for premium, healthy animal products and the expanding count of farm animals. By 2022, almost 20 million dairy cows will be found just in Europe. Efforts for animal illness prevention are also bringing AMR testing more front stage. Additionally expected to assist the sector expand are government backing, new technology, and more research alliances. Still, obstacles still exist. Some veterinarians are not completely aware of AMR testing, rules can be a challenge, and rising issues concerning AMR may influence future need for AMR testing.

Veterinary Antimicrobial Susceptibility Testing Market Trends
Faster and more accurate testing findings are made possible by the growing acceptance of fast diagnostics including automated systems and molecular approaches. Responsible antibiotic usage is being encouraged by the increasing focus veterinary clinics are paying on running antimicrobial stewardship initiatives. Data analytics and artificial intelligence (AI) combined into testing systems is helping to better understand susceptibility data and direct treatment recommendations. Further providing improved efficiency and cost-effectiveness, multiplex testing platforms that identify several antimicrobial resistances concurrently are becoming more and more popular.
Veterinary Antimicrobial Susceptibility Testing Market Analysis
Based on product, the market value from the automated AST instruments segment is projected to rise at impressive pace through 2032 owing to the increasing demand for fast and accurate testing results. For veterinary practices, automation lowers turnaround time and personnel costs and simplifies testing procedures. Advanced technologies include artificial intelligence improve data processing and interpretation, therefore increasing the dependability and efficiency of automated AST equipment. Using creative computer software, the equipment generates error-free results and helps each creature analyze its susceptibility pattern.
By 2032, the veterinary antimicrobial susceptibility testing market is expected to be dominated by the animal health sector—especially in the cattle sector. The increased need for antibiotics and other drugs for farm animals all around drives this explosion. Globally, antimicrobial sales are predicted to rise by 11.5% by 2030, totalling 104,079 tons according data from the National Library of Medicine. Given their possible abuse and this dramatic rise in microbiological sales, susceptibility testing is becoming rather important. Moreover, worries about food safety and the rise of antibiotic resistance force farmers to give frequent susceptibility testing top attention. They understand that both customers and animals depend on these drugs to remain effective, hence they must be safeguarded. Furthermore fast, more accurate, and more efficient antimicrobial susceptibility testing is becoming possible in cattle environments thanks to developments in testing technologies including rapid diagnostic approaches. These developments are facilitating producers' management of antibiotic resistance and preservation of animal health.
Given the rising frequency of antibiotic-resistant diseases in animals, North America veterinary antimicrobial susceptibility testing market size is expected to grow at very remarkable pace between 2024 and 2032. Strict rules are encouraging appropriate antimicrobial usage and raising veterinarian and animal owner knowledge of the need of susceptibility testing. Strong presence of established veterinary diagnostics companies and fast advancements in testing technologies will also help the regional sector development.

Veterinary Antimicrobial Susceptibility Testing Market Share
Companies operating in the veterinary antimicrobial susceptibility testing industry are adopting various corporate strategies, such as mergers & acquisitions and partnerships to come up with new innovative solutions and expand their consumer base.
Some of the major veterinary antimicrobial susceptibility testing companies are
- BioMérieux SA
- Thermo Fisher Scientific
- Bruker Corporation
- Danaher Corporation
- Becton Dickinson & Company
- Synbiosis
- Liofilchem S.r.l.
- HiMedia Laboratories
- Bio-Rad Laboratories
- Neogen Corporation
- Mast Group Ltd.
- Condalab
- FASTinov
- Hardy Diagnostics
- Bioguard Corporation
- SSI Diagnostica A/S
Veterinary Antimicrobial Susceptibility Testing Industry News
- In August 2022, Becton, Dickinson, and Company partnered with Accelerate Diagnostics to globally distribute Accelerate's rapid antibiotic resistance and susceptibility testing solution with the aim to provide results within hours.
What Information does this report contain?
Historical data coverage 2018 to 2023; Growth Projections 2024 to 2032.
Expert analysis industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts major segments covering applications, top products and geographies.
Competitive landscape reporting market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.